Quest, Labcorp Push Alzheimer’s Test Quest Diagnostics and Labcorp are now offering Fujirebio’s Lumipulse test, the first Food and Drug Administration-cleared blood-based assay for confirming Alzheimer’s disease in patients over age 50 with mild cognitive decline. The test offers a less invasive and more affordable alternative to PET scans or spinal taps. Early diagnosis of […]
National Lab Company Briefs
- By Scott Wallask
- > From the Volume XXXII, No. 14 - October 6, 2025 Issue
- Tags: Azlheimer’s, BioReference Health, biotech, Cairo Diagnostics, Fujirebio, G2 Intelligence, Hematopathology, LabCorp, Lumipulse, New Jersey Department of Labor and Workforce Development, OPKO Health, PET scan, Quest, Rye Management and Logistics Corp., Sonic Healthcare USA, spinal tap, the dark report
